Protocol Ledger

NCT07687706 · Phase III · RECRUITING

Tegoprazan for Prevention of Gastrointestinal Complication in Ischemic Stroke Patients on Antiplatelet Therapy (TegoStroke)

Interventional Phase III clinical trial protocol NCT07687706 sponsored by Hanyang University Guri Hospital in Neurology, Psychiatry, and Pain, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2026-01-26 Enrollment: 1,524 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT07687706
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)1,524 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)3 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT07687706
Protocol FieldVerified Registry Value
NCT IdentifierNCT07687706
Consolidated Lead SponsorHanyang University Guri Hospital
Therapeutic Condition CohortNeurology, Psychiatry, and Pain
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment1,524 participants (ESTIMATED)
Registered Start Date2026-01-26
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT07687706
Hospital Research SiteLocationSite Profile
Pusan National University HospitalBusan, South KoreaOpen Hospital Dossier ->
Keimyung University, Dongsan hospitalDaegu, South KoreaOpen Hospital Dossier ->
Chungbuk National University HospitalCheongju-si, South KoreaOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Neurology, Psychiatry, and Pain Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI